Polyglycerol-coated nanodiamond as a macrophage-evading platform for selective drug delivery in cancer cells

Biomaterials

Volumn 35, Issue 20, 2014, Pages 5393-5406

  Zhao, Li ^a   Xu, Yong Hong ^b   Akasaka, Tsukasa ^c   Abe, Shigeaki ^c   Komatsu, Naoki ^a   Watari, Fumio ^c   Chen, Xiao ^c  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cancer cells; Coating; Detonation nanodiamond; Polyglycerol; RGD peptide; Selective delivery

Indexed keywords

CHEMOTHERAPY; COATINGS; CYTOLOGY; DETONATION; DRUG DELIVERY; NANODIAMONDS; ORGANIC POLYMERS; PEPTIDES; TOXICITY; TUMORS;

CANCER CELLS; DETONATION NANODIAMOND; POLYGLYCEROLS; RGD PEPTIDE; SELECTIVE DELIVERY;

MACROPHAGES;

ANTINEOPLASTIC ANTIBIOTIC; ARGINYL-GLYCYL-ASPARTIC ACID; DOXORUBICIN; DRUG CARRIER; GLYCEROL; LIPOSOME; NANODIAMOND; OLIGOPEPTIDE; POLYGLYCEROL; POLYMER; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; MACROPHAGE; METABOLISM; NEOPLASMS; PHAGOCYTOSIS; PROCEDURES; TUMOR CELL LINE; U937 CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GLYCEROL; HUMANS; LIPOSOMES; MACROPHAGES; NANODIAMONDS; NEOPLASMS; OLIGOPEPTIDES; PHAGOCYTOSIS; POLYMERS; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 84899486970     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.03.041     Document Type: Article

References (42)

1. Davies L.C., Jenkins S.J., Allen J.E., Taylor P.R. Tissue-resident macrophages. Nat Immunol 2013, 14:986-995.
2. Moghimi S.M., Hunter C. Capture of stealth nanoparticles by the body's defences. Crit Rev Ther Drug Carrier Syst 2001, 18:527-550.
3. Ernsting M.J., Murakami M., Roy A., Li S.-D. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. JControl Release 2013, 172:782-794.
4. Moon J.J., Huang B., Irvine D.J. Engineering nano- and microparticles to tune immunity. Adv Mater 2012, 24:3724-3746.
5. Andersen A.J., Wibroe P.P., Moghimi S.M. Perspectives on carbon nanotube-mediated adverse immune effects. Adv Drug Deliv Rev 2012, 64:1700-1705.
6. Alexander-Bryant A.A., Vanden Berg-Foels W.S., Wen X. Bioengineering strategies for designing targeted cancer therapies. Adv Cancer Res 2013, 118:1-59.
7. Koo H., Huh M.S., Sun I.-C., Yuk S.H., Choi K., Kim K., et al. Invivo targeted delivery of nanoparticles for theranosis. Acc Chem Res 2011, 44:1018-1028.
8. Saha K., Kim S.T., Yan B., Miranda O.R., Alfonso F.S., Shlosman D., et al. Surface functionality of nanoparticles determines cellular uptake mechanisms in mammalian cells. Small 2013, 9:300-305.
9. Amoozgar Z., Yeo Y. Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012, 4:219-233.
10. Dominska M., Dykxhoorn D.M. Breaking down the barriers: siRNA delivery and endosome escape. JCell Sci 2010, 123:1183-1189.
11. Ishida T., Wang X., Shimizu T., Nawata K., Kiwada H. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner. JControl Release 2007, 122:349-355.
12. 2 nanoparticles for targeting ovarian cancer cells. Biomaterials 2011, 32:2166-2173.
13. Zhao L., Takimoto T., Ito M., Kitagawa N., Kimura T., Komatsu N. Chromatographic separation of highlysoluble diamond nanoparticles prepared by polyglycerol grafting. Angew Chem Int Ed 2011, 50:1388-1392.
14. Hofmann A.M., Wurm F., Hühn E., Nawroth T., Langguth P., Frey H. Hyperbranched polyglycerol-based lipids via oxyanionic polymerization: toward multifunctional stealth liposomes. Biomacromolecules 2010, 11:568-574.
15. Arsalani N., Fattahi H., Laurent S., Burtea C., Elst L.V., Muller R.N. Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging. Contrast Media Mol Imaging 2012, 7:185-194.
16. Kainthan R.K., Hester S.R., Levin E., Devine D.V., Brooks D.E. Invitro biological evaluation of high molecular weight hyperbranched polyglycerols. Biomaterials 2007, 28:4581-4590.
17. Maruyama K., Okuizumi S., Ishida O., Yamauchi H., Kikuchi H., Iwatsuru M. Phosphatidyl polyglycerols prolong liposome circulation invivo. Int J Pharm 1994, 111:103-107.
18. Calderón M., Quadir M.A., Sharma S.K., Haag R. Dendritic polyglycerols for biomedical applications. Adv Mater 2010, 22:190-218.
19. Sisson A.L., Steinhilber D., Rossow T., Welker P., Licha K., Haag R. Biocompatible functionalized polyglycerol microgels with cell penetrating properties. Angew Chem Int Ed 2009, 48:7540-7545.
20. Mochalin V.N., Shenderova O., Ho D., Gogotsi Y. The properties and applications of nanodiamonds. Nat Nanotechnol 2012, 7:11-23.
21. Manus L.M., Mastarone D.J., Waters E.A., Zhang X.Q., Schultz-Sikma E.A., Macrenaris K.W., et al. Gd(III)-nanodiamond conjugates for MRI contrast enhancement. Nano Lett 2010, 10:484-489.
22. Hegyi A., Yablonovitch E. Molecular imaging by optically detected electron spin resonance of nitrogen-vacancies in nanodiamonds. Nano Lett 2013, 13:1173-1178.
23. Zhang X.-Q., Lam R., Xu X., Chow E.K., Kim H.-J., Ho D. Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic efficacy. Adv Mater 2011, 23:4770-4775.
24. Zhang X.-Q., Chen M., Lam R., Xu X., Osawa E., Ho D. Polymer-functionalized nanodiamond platforms as vehicles for gene delivery. ACS Nano 2009, 3:2609-2616.
25. 4 nanoparticles as a novel magnetic resonance imaging contrast agent: an invitro assessment. Adv Funct Mater 2009, 19:2615-2622.
26. Chang Y., Lee H., Chen K., Chang C., Tsai D., Fu C., et al. Mass production and dynamic imaging of fluorescent nanodiamonds. Nat Nanotechnol 2008, 3:284-288.
27. Faklaris O., Joshi V., Irinopoulou T., Tauc P., Sennour M., Girard H., et al. Photoluminescent diamond nanoparticles for cell labeling: study of the uptake mechanism in mammalian cells. ACS Nano 2009, 3:3955.
28. Mohan N., Chen C.S., Hsieh H.H., Wu Y.C., Chang H.C. Invivo imaging and toxicity assessments of fluorescent nanodiamonds in caenorhabditis elegans. Nano Lett 2010, 10:3692-3699.
29. Zhao L., Xu Y.-H., Qin H., Abe S., Akasaka T., Chano T., et al. Platinum on nanodiamond: a promising prodrug conjugated with stealth polyglycerol, targeting peptide, and acid-responsive antitumor drug. Adv Funct Mater 2014, 10.1002/adfm.201304298.
30. 3 in complex with an Arg-Gly-Asp ligand. Science 2002, 296:151-155.
31. 3 integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. ACS Nano 2012, 6:4530-4539.
32. Zhao L., Shiino A., Qin H., Kimura T., Komatsu N. Synthesis, characterization, and magnetic resonance evaluation of polyglycerol-functionalized detonation nanodiamond conjugated with gadolinium(III) complex. JNanosci Nanotechnol 2014, In press.
33. Zhao L., Chano T., Morikawa S., Saito Y., Shiino A., Shimizu S., et al. Hyperbranched polyglycerol-grafted superparamagnetic iron oxide nanoparticles: synthesis, characterization, functionalization, size separation, magnetic properties, and biological applications. Adv Funct Mater 2012, 22:5107-5117.
34. Sintiprungrat K., Singhto N., Sinchaikul S., Chen S.-T., Thongboonkerd V. Alterations in cellular proteome and secretome upon differentiation from monocyte to macrophage by treatment with phorbol myristate acetate: Insights into biological processes. JProteomics 2010, 73:602-618.
35. Quah B.J.C., Parish C.R. The use of carboxyfluorescein diacetate succinimidyl ester (CFSE) to monitor lymphocyte proliferation. JVis Exp 2010, e2259.
36. Wang F., Wang Y.-C., Dou S., Xiong M.-H., Sun T.-M., Wang J. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano 2011, 5:3679-3692.
37. Hu X., Liu S., Huang Y., Chen X., Jing X. Biodegradable block copolymer-doxorubicin conjugates via different linkages: preparation, characterization, and invitro evaluation. Biomacromolecules 2010, 11:2094-2102.
38. Siegers C., Biesalski M., Haag R. Self-assembled monolayers of dendritic polyglycerol derivatives on gold that resist the adsorption of proteins. Chem Eur J 2004, 10:2831-2838.
39. Fornari F.A., Randolph J.K., Yalowich J.C., Ritke M.K., Gewirtz D.A. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol 1994, 45:649-656.
40. Gewirtz D. Acritical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 1999, 57:727-741.
41. Delehanty J.B., Boeneman K., Bradburne C.E., Robertson K., Bongard J.E., Medintz I.L. Peptides for specific intracellular delivery and targeting of nanoparticles: implications for developing nanoparticle-mediated drug delivery. Ther Deliv 2010, 1:411-433.
42. 3 integrin agents. JNeurooncol 2000, 46:135-144.